A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease
Conditions: Sickle Cell Disease; Sickle Cell Nephropathy Intervention: Drug: Voxelotor Sponsors: University of Illinois at Chicago; Global Blood Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials